Found: 28
Select item for more details and to access through your institution.
Adjuvant treatment recommendations for patients with ER-positive/HER2-negative early breast cancer by Swiss tumor boards using the 21-gene recurrence score (SAKK 26/10).
- Published in:
- 2017
- By:
- Publication type:
- journal article
Mutational analysis of triple-negative breast cancers within the International Breast Cancer Study Group (IBCSG) Trial 22-00.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 170, n. 2, p. 351, doi. 10.1007/s10549-018-4767-1
- By:
- Publication type:
- Article
Team functioning across different tumour types: Insights from a Swiss cancer center using qualitative and quantitative methods.
- Published in:
- Cancer Reports, 2022, v. 5, n. 8, p. 1, doi. 10.1002/cnr2.1541
- By:
- Publication type:
- Article
Association of Axillary Dissection With Systemic Therapy in Patients With Clinically Node-Positive Breast Cancer.
- Published in:
- JAMA Surgery, 2023, v. 158, n. 10, p. 1013, doi. 10.1001/jamasurg.2023.2840
- By:
- Publication type:
- Article
Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
- Published in:
- 2018
- By:
- Publication type:
- journal article
Plasma HER2ECD a promising test for patient prognosis and prediction of response in HER2 positive breast cancer: results of a randomized study - SAKK 22/99.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Standardization for Ki-67 Assessment in Moderately Differentiated Breast Cancer. A Retrospective Analysis of the SAKK 28/12 Study.
- Published in:
- PLoS ONE, 2015, v. 10, n. 4, p. 1, doi. 10.1371/journal.pone.0123435
- By:
- Publication type:
- Article
Cervical and vaginal cancer in a woman with chronic graft-versus-host disease
- Published in:
- 2011
- By:
- Publication type:
- journal article
Oesophageal cancer: exploring controversies overview of experts' opinions of Austria, Germany, France, Netherlands and Switzerland.
- Published in:
- Radiation Oncology, 2015, v. 10, n. 1, p. 1, doi. 10.1186/s13014-015-0418-4
- By:
- Publication type:
- Article
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2-negative advanced stage breast cancer - a multicenter, randomized phase III trial.
- Published in:
- 2016
- By:
- Publication type:
- journal article
SAKK 24/09: safety and tolerability of bevacizumab plus paclitaxel vs. bevacizumab plus metronomic cyclophosphamide and capecitabine as first-line therapy in patients with HER2- negative advanced stage breast cancer - a multicenter, randomized phase III trial
- Published in:
- BMC Cancer, 2016, v. 16, p. 1, doi. 10.1186/s12885-016-2823-y
- By:
- Publication type:
- Article
Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple-negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-00.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 2, p. 323, doi. 10.1007/s10549-016-3863-3
- By:
- Publication type:
- Article
Ki-67 assessment in early breast cancer: SAKK28/12 validation study on the IBCSG VIII and IBCSG IX cohort.
- Published in:
- Scientific Reports, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1038/s41598-019-49638-4
- By:
- Publication type:
- Article
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. 1, doi. 10.1177/1758835918818351
- By:
- Publication type:
- Article
Predicting mortality and adverse events in patients with advanced pancreatic cancer treated with palliative gemcitabine-based chemotherapy in a multicentre phase III randomized clinical trial: the APC-SAKK risk scores.
- Published in:
- Therapeutic Advances in Medical Oncology, 2019, v. 11, p. N.PAG, doi. 10.1177/1758835918818351
- By:
- Publication type:
- Article
ASCO 2020.
- Published in:
- 2020
- By:
- Publication type:
- Interview
Brustzentrum Kantonsspital St. Gallen – von der Multidisziplinarität zur patientinnenzentrierten interdisziplinären Betriebsorganisation.
- Published in:
- Breast Care, 2010, v. 5, n. 3, p. 188, doi. 10.1159/000315353
- By:
- Publication type:
- Article
Heated (37 degrees C) oxaliplatin infusion in combination with capecitabine for metastatic colorectal carcinoma: can it reduce neuropathy?
- Published in:
- 2010
- By:
- Publication type:
- journal article
Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
- Published in:
- 2009
- By:
- Publication type:
- journal article
Skeletal muscle mass correlates with increased toxicity during neoadjuvant radiochemotherapy in locally advanced esophageal cancer: A SAKK 75/08 substudy.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Correction: Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
- Published in:
- 2020
- By:
- Publication type:
- corrected article
Quality of life under extended continuous versus intermittent adjuvant letrozole in lymph node-positive, early breast cancer patients: the SOLE randomised phase 3 trial.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Long-term responders to trastuzumab monotherapy in first-line HER-2+ advanced breast cancer: characteristics and survival data.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Eurythmy therapy versus slow movement fitness in the treatment of fatigue in metastatic breast cancer patients: study protocol for a randomized controlled trial.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Breast Cancer Patients on Endocrine Therapy Reveal More Symptoms when Self-Reporting than in Pivotal Trials: An Outcome Research Study.
- Published in:
- Oncology, 2009, v. 76, n. 2, p. 142, doi. 10.1159/000195540
- By:
- Publication type:
- Article
Pegylated Liposomal Doxorubicin (Caelyx®) in Metastatic Breast Cancer: A Community-Based Observation Study.
- Published in:
- Oncology, 2007, v. 72, n. 3/4, p. 147, doi. 10.1159/000112731
- By:
- Publication type:
- Article
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors.
- Published in:
- BMC Cancer, 2013, v. 13, n. 1, p. 1, doi. 10.1186/1471-2407-13-153
- By:
- Publication type:
- Article
Cross-sectional study of self-reported physical activity, eating habits and use of complementary medicine in breast cancer survivors.
- Published in:
- 2013
- By:
- Publication type:
- journal article